ticlopidine has been researched along with Atrial Septal Defect in 13 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 7.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| "The present study was undertaken to evaluate the safety and release of nickel after implantation of a nickel device (Amplatzer occluder) in patients with an atrial septal defect (ASD) receiving antiplatelet therapy." | 7.73 | Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder. ( Brandt, R; Burian, M; Geisslinger, G; Hamm, C; Mitrovic, V; Neumann, T; Weber, M, 2006) |
| "The occurrence of new-onset migraine attacks is a complication of transcatheter atrial septal defect (ASD) closure." | 6.80 | Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial. ( Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J, 2015) |
| "De novo onset or aggravation of migraine has been observed after atrial septal defect closure (ASDC), whereas antiplatelet drugs, such as clopidogrel, used to prevent post-ASDC thromboembolic events, have been associated with migraine amelioration." | 5.38 | Atrial septal defect closure and de novo migraine: Exclusive ticlopidine efficacy. ( Benemei, S; Geppetti, P; Giusti, B; Marcucci, R; Rossi, E, 2012) |
| "Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine." | 5.34 | Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007) |
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 3.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| "The present study was undertaken to evaluate the safety and release of nickel after implantation of a nickel device (Amplatzer occluder) in patients with an atrial septal defect (ASD) receiving antiplatelet therapy." | 3.73 | Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder. ( Brandt, R; Burian, M; Geisslinger, G; Hamm, C; Mitrovic, V; Neumann, T; Weber, M, 2006) |
| "The occurrence of new-onset migraine attacks is a complication of transcatheter atrial septal defect (ASD) closure." | 2.80 | Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial. ( Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J, 2015) |
| "De novo onset or aggravation of migraine has been observed after atrial septal defect closure (ASDC), whereas antiplatelet drugs, such as clopidogrel, used to prevent post-ASDC thromboembolic events, have been associated with migraine amelioration." | 1.38 | Atrial septal defect closure and de novo migraine: Exclusive ticlopidine efficacy. ( Benemei, S; Geppetti, P; Giusti, B; Marcucci, R; Rossi, E, 2012) |
| "A perimembranous ventricular septal defect (7 mm) and an ostium secundum atrial septal defect (8." | 1.37 | [Simultaneous transcatheter treatment of perimembranous ventricular septal defect and secundum atrial septal defect in an adult: first application in Turkey]. ( Arı, H; Arı, S; Bozat, T; Koca, V, 2011) |
| "Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine." | 1.34 | Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seo, JB | 1 |
| Park, KW | 1 |
| Lee, HY | 1 |
| Kang, HJ | 1 |
| Koo, BK | 1 |
| Kim, SH | 1 |
| Kim, HS | 1 |
| Rodés-Cabau, J | 1 |
| Horlick, E | 1 |
| Ibrahim, R | 1 |
| Cheema, AN | 1 |
| Labinaz, M | 1 |
| Nadeem, N | 1 |
| Osten, M | 1 |
| Côté, M | 1 |
| Marsal, JR | 1 |
| Rivest, D | 1 |
| Marrero, A | 1 |
| Houde, C | 1 |
| Huynh, K | 1 |
| Arı, H | 1 |
| Arı, S | 1 |
| Koca, V | 1 |
| Bozat, T | 1 |
| Benemei, S | 1 |
| Rossi, E | 1 |
| Marcucci, R | 1 |
| Giusti, B | 1 |
| Geppetti, P | 1 |
| Fries, R | 1 |
| Böhm, M | 1 |
| Jessup, DB | 1 |
| Coletti, AT | 1 |
| Muhlestein, JB | 1 |
| Barry, WH | 1 |
| Shean, FC | 1 |
| Whisenant, BK | 1 |
| Elkind, MS | 1 |
| Sharifi, M | 2 |
| Burks, J | 2 |
| Dehghani, M | 1 |
| Mehdipour, M | 1 |
| Al-Bustami, O | 1 |
| Emrani, F | 1 |
| Wilmshurst, PT | 1 |
| Nightingale, S | 1 |
| Walsh, KP | 1 |
| Morrison, WL | 1 |
| Burian, M | 1 |
| Neumann, T | 1 |
| Weber, M | 1 |
| Brandt, R | 1 |
| Geisslinger, G | 1 |
| Mitrovic, V | 1 |
| Hamm, C | 1 |
| Tomita, H | 1 |
| Hatakeyama, K | 1 |
| Soda, W | 1 |
| Kobayashi, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clopidogrel On Top of Aspirin For the Prevention of New Onset Migraine Headache Occurrence Following Transcatheter Closure of Atrial Septal Defects: A Prospective Randomized Trial (the CANOA Study)[NCT00799045] | Phase 4 | 220 participants (Actual) | Interventional | 2008-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ticlopidine and Atrial Septal Defect
| Article | Year |
|---|---|
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure].
Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Ant | 2003 |
The role of warfarin and aspirin in secondary prevention of stroke.
Topics: Anticoagulants; Aspirin; Clopidogrel; Heart Septal Defects, Atrial; Humans; Ischemic Attack, Transie | 2004 |
1 trial available for ticlopidine and Atrial Septal Defect
| Article | Year |
|---|---|
Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.
Topics: Aspirin; Cardiac Catheterization; Cardiac Surgical Procedures; Clopidogrel; Double-Blind Method; Dru | 2015 |
10 other studies available for ticlopidine and Atrial Septal Defect
| Article | Year |
|---|---|
Comparison of Angiographic Outcomes of Side Branch Ostium at Bifurcation Coronary Lesion between Two-stent and One-stent Techniques.
Topics: Aspirin; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; F | 2015 |
Antiplatelet therapy: Clopidogrel plus aspirin reduces migrane attacks after ASD closure.
Topics: Aspirin; Cardiac Catheterization; Cardiac Surgical Procedures; Female; Headache Disorders, Secondary | 2016 |
[Simultaneous transcatheter treatment of perimembranous ventricular septal defect and secundum atrial septal defect in an adult: first application in Turkey].
Topics: Anesthetics, Intravenous; Clopidogrel; Echocardiography, Transesophageal; Female; Fluoroscopy; Heart | 2011 |
Atrial septal defect closure and de novo migraine: Exclusive ticlopidine efficacy.
Topics: Adult; Cardiovascular Surgical Procedures; Female; Fibrinolytic Agents; Heart Septal Defects, Atrial | 2012 |
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardia | 2003 |
Efficacy of clopidogrel in the treatment of post-ASD closure migraines.
Topics: Balloon Occlusion; Clopidogrel; Epilepsy; Heart Septal Defects, Atrial; Humans; Migraine Disorders; | 2004 |
Intense migraines secondary to percutaneous closure of atrial septal defects.
Topics: Adult; Cardiac Catheterization; Clopidogrel; Echocardiography, Transesophageal; Female; Follow-Up St | 2005 |
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Septa | 2005 |
Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder.
Topics: Adult; Aged; Alloys; Aspirin; Clopidogrel; Female; Heart Septal Defects, Atrial; Humans; Male; Middl | 2006 |
Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report.
Topics: Adolescent; Cardiac Catheterization; Female; Heart Septal Defects, Atrial; Humans; Migraine with Aur | 2007 |